Browse by author
Lookup NU author(s): Emeritus Professor Philip Home
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
OBJECTIVETo compare the efficacy and safety of new insulin glargine 300 units/mL (Gla-300) with glargine 100 units/mL (Gla-100) in people with type 2 diabetes on basal insulin (>= 42 units/day) plus mealtime insulin.RESEARCH DESIGN AND METHODSEDITION 1 (NCT01499082) was a 6-month, multinational, open-label, parallel-group study. Adults with glycated hemoglobin A(1c) (HbA(1c)) 7.0-10.0% (53-86 mmol/mol) were randomized to Gla-300 or Gla-100 once daily with dose titration seeking fasting plasma glucose 4.4-5.6 mmol/L. Primary end point was HbA(1c) change from baseline; main secondary end point was percentage of participants with one or more confirmed (<= 3.9 mmol/L) or severe nocturnal hypoglycemia from week 9 to month 6.RESULTSParticipants (n = 807) had mean age 60 years, diabetes duration 16 years, BMI 36.6 kg/m(2), and HbA(1c) 8.15% (65.6 mmol/mol). HbA(1c) reduction was equivalent between regimens; least squares mean difference -0.00% (95% CI -0.11 to 0.11) (-0.00 mmol/mol [-1.2 to 1.2]). Fewer participants reported one or more confirmed (<= 3.9 mmol/L) or severe nocturnal hypoglycemic events between week 9 and month 6 with Gla-300 (36 vs. 46% with Gla-100; relative risk 0.79 [95% CI 0.67-0.93]; P < 0.005); nocturnal hypoglycemia incidence and event rates were also lower with Gla-300 in the first 8 weeks of treatment. No between-treatment differences in tolerability or safety were identified.CONCLUSIONSGla-300 controls HbA(1c) as well as Gla-100 for people with type 2 diabetes treated with basal and mealtime insulin but with consistently less risk of nocturnal hypoglycemia.
Author(s): Riddle MC, Bolli GB, Ziemen M, Muehlen-Bartmer I, Bizet F, Home PD, Edition 1 Study Investigators
Publication type: Article
Publication status: Published
Journal: Diabetes Care
Year: 2014
Volume: 37
Issue: 10
Pages: 2755-2762
Print publication date: 23/09/2014
Online publication date: 30/07/2014
Acceptance date: 12/06/2014
ISSN (print): 0149-5992
ISSN (electronic): 1935-5548
Publisher: American Diabetes Association
URL: http://dx.doi.org/10.2337/dc14-0991
DOI: 10.2337/dc14-0991
Altmetrics provided by Altmetric
